Beta-D-Glucan in Patients with Haematological Malignancies
(1-3)-beta-D-glucan (BDG) is an almost panfungal marker (absent in zygomycetes and most cryptococci), which can be successfully used in screening and diagnostic testing in patients with haematological malignancies if its advantages and limitations are known. The aim of this review is to report the d...
المؤلفون الرئيسيون: | Malgorzata Mikulska, Elisa Balletto, Elio Castagnola, Alessandra Mularoni |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
MDPI AG
2021-12-01
|
سلاسل: | Journal of Fungi |
الموضوعات: | |
الوصول للمادة أونلاين: | https://www.mdpi.com/2309-608X/7/12/1046 |
مواد مشابهة
-
Isavuconazole Treatment of Spinal Cord Invasive Aspergillosis Guided by Cerebrospinal Fluid (1,3)-β-d-Glucan Levels in a Patient with Low Interferon-Gamma and Ulcerative Colitis
حسب: Siobhan O’Regan, وآخرون
منشور في: (2022-05-01) -
Invasive Fungal Infections in Hospitalized Patients with COVID-19: A Non-Intensive Care Single-Centre Experience during the First Pandemic Waves
حسب: Letizia Cattaneo, وآخرون
منشور في: (2023-01-01) -
Invasive Fungal Infections in Persons Living with HIV in an Amazonian Context: French Guiana, 2009–2019
حسب: Laurène Cachera, وآخرون
منشور في: (2021-05-01) -
Serum Beta-D-Glucan in the Diagnosis of Invasive Fungal Disease in Neonates, Children and Adolescents: A Critical Analysis of Current Data
حسب: Laura Ferreras-Antolin, وآخرون
منشور في: (2022-11-01) -
Epidemiology of Systemic Mycoses in the COVID-19 Pandemic
حسب: María Guadalupe Frías-De-León, وآخرون
منشور في: (2021-07-01)